目的：评估髂内动脉灌注化疗联合放疗治疗浸润性膀胱癌的有效性及安全性。
Objective: To evaluate the efficacy of bladder sparing treatment by internal iliac arterial infusion chemotherapy and radiotherapy in invasive bladder carcinoma.
结论BCG灌注或者联合其他灌注方法能有效降低浅表膀胱癌术后的复发率。
Conclusions Only BCG instillation and combined instillation of BCG and other drugs could effectively lower recurrence of superficial bladder carcinoma after surgical operation.
结论P -糖蛋白介导的多药耐药是膀胱癌腔内灌注化疗失败、肿瘤复发的重要原因。
Conclusion the P-glycoprotein-mediated MDR may be an important cause of recurrent of bladder cancer after treated by perfusion chemotherapy.
对浅表性膀胱癌灌注治疗的研究进展进行综述。
In this review, we discuss the advancement of the intravesical infusion therapy of superficial bladder cancer.
自1996年1月至今，我科为12例晚期膀胱癌患者施行了髂内动脉灌注化疗。
From Jan 1996 to Jun 1998, 12 patients with advanced or moderately advanced cancer of urinary bladder were treated by arterial infusion chemotherapy.
自1996年1月至今，我科为12例晚期膀胱癌患者施行了髂内动脉灌注化疗。
From Jan 1996 to Jun 1998, 12 patients with advanced or moderately advanced cancer of urinary bladder were treated by arterial infusion chemotherapy.
应用推荐